Aspergillus sensitization as a treatable trait in COPD

P. Tiew (Singapore, Singapore), J. Narayana (Singapore, Singapore), M. Quek (Singapore, Singapore), Y. Ang (Singapore, Singapore), F. Ko (Singapore, Singapore), M. Poh (Kuala Lumpur, Singapore), T. Jaggi (Singapore, Singapore), H. Xu (Singapore, Singapore), K. Thng (Singapore, Singapore), M. Koh (Singapore, Singapore), A. Tee (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), K. Tsaneva-Atanasova (Exeter, United Kingdom), F. Chew (Singapore, Singapore), S. Chotirmall (Singapore, Singapore)

Source: International Congress 2022 – Fungal infections and other relevant COVID-19 findings

Session: Fungal infections and other relevant COVID-19 findings
Session type: Thematic Poster
Number: 1878

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Tiew (Singapore, Singapore), J. Narayana (Singapore, Singapore), M. Quek (Singapore, Singapore), Y. Ang (Singapore, Singapore), F. Ko (Singapore, Singapore), M. Poh (Kuala Lumpur, Singapore), T. Jaggi (Singapore, Singapore), H. Xu (Singapore, Singapore), K. Thng (Singapore, Singapore), M. Koh (Singapore, Singapore), A. Tee (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), K. Tsaneva-Atanasova (Exeter, United Kingdom), F. Chew (Singapore, Singapore), S. Chotirmall (Singapore, Singapore). Aspergillus sensitization as a treatable trait in COPD. 1878

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.